[29P01-028] The absolute stereostructure of novel macrolide produced by a marine alga-derived fungus.

○Takeshi Yamada¹, Minami Kataoka¹, Takashi Kikuchi¹, Tomoya Hirano¹ (1. Osaka Univ. Pharm. Sci.)

[29P01-029] Structure elucidation of three new carbazole alkaloids from Murraya euchrestifolia and the inhibitory effect of human cancer cell proliferation of the isolated compounds

○Chihiro Ito¹, Aya Iwase¹, Takuya Matsui², Masataka Itoigawa³, Tian-Shung Wu⁴ (1. Faculty of Pharmacy, Meijo Univ., 2. Aichi Medical Univ., 3. Tokai Gakuen Univ., 4. National Cheng Kung Univ.)

[29P01-030S] Isolation and structure elucidation of peniphilones A and B

○Yuhei Koyanagi¹, Yuki Hitora¹, Teppei Kawahara¹, Sachiko Tsukamoto¹ (1. Grad. Sch. Pharm. Sci., Kumamoto Univ.)

[29P01-031S] Development of new nitrogen-containing compounds using component derived from Isatis tinctoria (Brassicaceae)

○Jousei Tsunooka¹, Seikou Nakamura¹, Kaori Ryu¹, Sakurako Hamamoto¹, Koya Miyagawa¹, Souichi Nakashima¹, Hisashi Matsuda¹ (1. Kyoto Pharmaceutical Univ.)

[29P01-032S] Fluoromethyl and difluoromethyl ether analogues of anti-tumor cyclic peptide RA-VII

○Xiaohan Ge¹, Tomoyo Hasuda¹, Yukio Hitotsuyanagi¹ (1. Pharm.Tokyo University of Pharmacy and Life Sciences)

[29P01-033S] Study on the chemical constituents of Zingiber officinale Roscoe

○Yuto Nishidono¹, Yasuhiro Tezuka², Ken Tanaka¹ (1. Col. Pharm. Sci., Ritsumeikan Univ., 2. Fac. Pharm. Sci., Hokuriku Univ.)

[29P01-034] Discovery of bioactive alkaloids targeting the lipid droplet accumulation (LDA) and oxidized lipid droplets oxLDs

○Dya Fita Dibwe¹, Oba Saki¹, Takeishi Nire¹, Rojeet Shrestha¹, Hitoshi Chiba², Shu-Ping Hui¹ (1. Faculty of Health Sciences, Hokkaido University, 2. Department of Nutrition, Sapporo University of Health Sciences)

[29P01-035S] Design and synthesis of β-carboline alkaloids and their anti-lipid droplet accumulation activity.

○Nire Takeishi¹, Dya Fita Dibwe¹, Saki Oba¹, Hitoshi Chiba², Shu-Ping Hui¹ (1. Grad. Sch. Health Sci., Hokkaido Univ., 2. Fac. Health Sci., Dep. Nutrition., Sapporo Univ.)

[29P01-036S] Direct derivatization of Allium extracts and their inhibitory effect on the free fatty acid-induced lipid droplet accumulation in HepG2 Hepatocyte

○Saki Oba¹, Dya Fita Dibwe¹, Nire Takeishi¹, Hitoshi Chiba², Shu-Ping Hui¹ (1. Grad. Sch. Health Sci., Hokkaido Univ., 2. Fac. Health Sci., Dep. Nutrition., Sapporo Univ.)

[29P01-037] Establishment of screening strategy for novel anticancer agents targeting cancer stem cells

○Hiroaki Ikeda¹, Misato Kawami¹, Masaya Imoto², Hideaki Kakeya¹ (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. Grad. Sch. Med., Juntendo Univ.)

[29P01-038] Synthesis of antiangiogenetic novel butenolide analogs with cis-epoxide side chain

○Satoru TAMURA¹, Keigo Sato¹, Reina Fujiwara¹, Yui Hirota¹, Miki Yamazaki¹, Maika Fushimi¹, Masayoshi Arai², Yuka Nakamura², Motomasa Kobayashi², Tomikazu Kawano¹ (1. School of Pharmacy, Iwate Medical Univ., 2. Grad. Sch. Pharmaceutical Sci., Osaka Univ.)

[29P01-039] Search for anti-hyaluronidase active compounds in fern plant extracts

○Hitomi Kawakami^1,2, Noriaki Kawano¹, Hiroyuki Fuchino^1,2, Nobuo Kawahara^1,2 (1. NIBIOHN, 2. Grad. Sch. of Pharm. Sci., Osaka Univ.)

[29P01-040] Exploring inhibitor of cancer exosome secretion from marine medicinal resources

○Jianyu Lin¹, Fumie Mitani^2,3, Chitose Oneyama^2,3, Masayoshi Arai¹ (1. Grad. Sch. Pharmaceutical Sci., Osaka Univ., 2. Aichi Cancer Res. Inst., 3. Grad. Sch. Pharmaceutical Sci., Nagoya City Univ.)

[29P01-041S] Construction of an evaluation system for the search for inhibitors targeting NUP98-HOXA9 in myeloid leukemia

○Fuki Moriya¹, Shohei Takase¹, Yun YoungSook¹, Katsunori Miyake², Tadahiro Yahagi³, Akihiro Ito¹, Hideshi Inoue¹ (1. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci., 2. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 3. Sch. Pharm., Nihon Univ.)

[29P01-042S] Screening study and identification of antiprotozoal compounds from entomopathogenic fungi

○Kosuke Saito¹, Tatsuro Yoneyama¹, Sayaka Ban², Masaaki Noji¹, Akemi Umeyama¹ (1. Pharm.Sci.,Tokushima Bunri Univ., 2. Medical Mycology Research Center,Chiba Univ.)

[29P01-043] anti-Herpes simplex virus type 1 activity of naturally occurring triterpens and their chemical stractural properties

○Keiko Ogawa¹, Seikou Nakamura², Kaori Ryu², Sako Nakamura², Souichi Nakashima², Rumiko Hosoki¹, Hisashi Matsuda² (1. Col. Pharm. Sci., Ristumeikan Univ., 2. Kyoto Pharm. Univ.)

[29P01-044] Screening for enhancer of chondrogenic differentiation from natural product library

○Satoshi Ohte¹, Sachiho Kaneda¹, Hiroshi Tomoda¹ (1. Grad. Sch. Pharm. Sci., Kitasato Univ.)

[29P01-045S] Search for antimalarial compounds from microbial metabolites having heme polymerization inhibitory activity

○Rima Koike¹, Yuki Shimizu¹, Aki Isiyama^1,2, Yosihiro Watanabe², Rei Hokari², Kenichi Nonaka^1,2, Yuki Inahashi^1,2, Masato Iwatsuki^1,2 (1. Grad. Sch. Infection Control Sci., Kitasato Univ., 2. Ōmura Inst., Kitasato Univ.)

[29P01-046S] Validation of the potential for nactins as seeds to develop the drug for Leishmaniasis

○Ayano Yamanaka¹, Rei Hokari², Yoshihiro Watanabe², Yuki Inahashi^1,2, Aki Ishiyama^1,2, Masato Iwatsuki^1,2 (1. Grad. Sch. Infection Control Sci., Kitasato Univ., 2. Ōmura Inst., Kitasato Univ.)

[29P01-047] Effects of Lepidium meyenii WALP (Maca) on growth of rats- second report-

○Tamaki Jikyo¹ (1. Dept. food and nutrition, Osaka Yuhigaoka Gakuen College)

[29P01-048] A fungal-derived antioxidant and its life-extending effect on C. elegans

○SATOSHI TAKAMATSU^1,2, SAHO IKEDA², NOZOMI ITO², SHIORI SATO², RIKU YAMANAKA², KEIKO ISHINO², KAYO YASUDA³, NAOAKI ISHI³, KAZUYOSHI KAWAZOE² (1. Fac. of Pharmaceu. Sci., Teikyo Heisei Univ., 2. Sch. Pharm. Showa Univ., 3. Sch. Health Stud. Tokai Univ.)

[29P01-049] The specificity of bioconversion for glycyrrhizin by endophytic fungus Phomopsis sp. associated with Glycyrrhiza uralensis

○Shoji Maehara¹, Tatsuyuki Umeda¹, Toshiyuki Hata¹ (1. Faculty of Pharm. and Pharm. Sci., Fukuyama Univ.)

[29P01-050] Structure analysis and bioactivity evaluation of new compounds from entomopathogenic fungi

○Tatsuro Yoneyama¹, Sayaka Ban², Masaaki Noji¹, Akemi Umeyama¹ (1. Faculty of Pharmaceutical Sciences, Tokushima Bunri Univ., 2. Medical Mycology Research Center, Chiba Univ.)

[29P01-051S] Study on a new anti-MAC agent produced by actinomycete strain Streptomyces sp. KKTA-0263

○Ayumi Hikima¹, Hiroshi Tomoda², Nobuhiro Koyama^1,2 (1. Grad. Sch. Pharm. Sci., Kitasato Univ., 2. Sch. Pharm., Kitasato Univ.)

[29P01-052] The study of nectriatide derivatives on antifungal activity of amphotericin B

○Keisuke Kobayashi¹, Ryosuke Miyake¹, Kenichiro Nagai¹, Hiroshi Tomoda¹ (1. Kitasato Univ. Sch. Pharm.)

[29P01-053S] Screening for PCSK9 inhibitors from a microbial compounds library.

○Akane Nakahara¹, Keisuke Kobayashi^1,2, Hiroshi Tomoda² (1. Grad. Sch. Pharm. Sci., Kitasato Univ., 2. Kitasato Univ., Sch. Pharm.)

Session information

[29P01] 生薬学・天然物化学⑤